Press release
Advantages of Asia-Pacific Precision Medicine Market: know about Trends, growing demand, Driving factors and key companies such as Pfizer, Novartis, Teva pharmaceuticals Industries etc.
Asia-Pacific is the fastest growing precision medicine market in the world. Major countries like China, India and Japan are adopting healthcare technologies at a rapid pace, resulting in improvements in the treatments and solutions for uncommon diseases. This is why the demand for precision medicine is also increasing. The market is expected to expand in the region because of advancements in recent research which are helping in the diagnosis of diseases, its appropriate risks and optimal therapy. According to Netscribes, the Asia-Pacific precision medicine market is projected to grow at a compound annual growth rate (CAGR) of 16.63%, leading to a revenue of USD 20.90 Bn by 2023.
Download Free Report Sample (PDF) Here: https://www.researchreporthub.com/report/asia-pacific-precision-medicine-market/11417/#requestforsample
China is dominating the precision medicine market due to its ageing population and rise in the rate of chronic diseases. India is experiencing the fastest growth in the Asia- Pacific region. Rising investments in research and development have also triggered the growth of the precision medicine market.
The Asia-Pacific precision medicine market is classified into three primary segments: based on ecosystem players: pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies; based on therapeutics: cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases; and based on technology: big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics.
Diagnostic tool companies are expected to exhibit the highest growth rate in the region due to increased investments in research and technology, and clinical trials in the region. The cancer therapeutics segment is expected to register the highest growth rate during the forecasted period 2018-2023 due to higher incidence of cancer.
Key growth factors
The adoption of gene therapy - which is essential for the development of precision medicine - is responsible for the growth of the market. Further, the increasing rate of chronic diseases and enhancements in big data analytics will also drive the precision medicine market during the forecasted period of 2018-2023.
Asia-Pacific is expected to become one of the most prominent markets by 2023 for precision medicine because of favorable reimbursement policies which will help businesses expand across borders.
Threats and key players
There is limited adoption (less than 50%) of electronic health records in Asia-Pacific countries like India, Indonesia, etc. This is resulting in the absence of proper healthcare information systems, which are important components of precision medicine to capture vital patient data. This limits the deployment of advanced healthcare solutions like precision medicine.
The adoption of high-end genomic technologies and artificial intelligence tools like N-of-One, WuxiNextCode, etc., are expected to face difficulties in the region due to inadequate healthcare facilities.
The major players operating in the Asia-Pacific precision medicine market are Pfizer, Novartis, Teva pharmaceuticals Industries etc.
Get Discount & Customization of this Report Here: https://www.researchreporthub.com/report/asia-pacific-precision-medicine-market/11417/
Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary
Chapter 2: Asia-Pacific precision medicine market - overview
2.1. Asia-Pacific market overview - market trends, drivers and challenges
2.2. Value chain analysis
2.3. Porters Five Forces analysis
2.4. Market size - by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
2.4. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. Market size - by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
2.5. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. b. Revenue from cardiovascular- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. c. Revenue from central nervous system - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. d. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. e. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. Market size - by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
2.6. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
Chapter 3: Asia-Pacific precision medicine market- by countries
3.1. China
3.1.1. Market overview - market trends, drivers and challenges
3.1.2. Market size - by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
3.1.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. Market size - By therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
3.1.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. Market size - By technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
3.1.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. India
3.2.1. Market overview - market trends, drivers and challenges
3.2.2. Market size - by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
3.2.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. Market size - By therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
3.2.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. Market size - By technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
3.2.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. Japan
3.3.1. Market overview - market trends, drivers and challenges
3.3.2. Market size - by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
3.3.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.3. Market size- By therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
3.3.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.4. Market size- By technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
3.3.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.4. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.4. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
…….
Get Complete TOC with Figures and Tables Here: https://www.researchreporthub.com/report/asia-pacific-precision-medicine-market/11417/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
Research Report Hub
20 Hanover Square
Mayfair, London W1S 1JY, UK
sales@researchreporthub.com
Web:www.researchreporthub.com
Find us on:
https://www.facebook.com/reasearchreporthub/
https://twitter.com/hub_report
https://www.linkedin.com/company/research-report-hub/
sales@researchreporthub.com
UK: +44 7441 906751
(US/CAN TOLL FREE):1 888-247-2308
Asia: +91 84484 44687
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advantages of Asia-Pacific Precision Medicine Market: know about Trends, growing demand, Driving factors and key companies such as Pfizer, Novartis, Teva pharmaceuticals Industries etc. here
News-ID: 1529113 • Views: …
More Releases from Research report hub
Global Wine Market is Booming with Market Strategies Adopted By Key Players like …
Wine is an alcoholic drink produced by the fermentation of grapes or other fruits.
Scope of the Report:
The Wine industry concentration is very low; there are about many manufacturers or wineries in the world, and the products mainly from Italy, France, Spain, Australia and USA.
Global manufactures mainly distributed in Europe, Australia and USA. The wineries in Europe have a long history and unshakable status in this field. Wineries in France relative…
Global Microfiber Leather Market Emerging Trends and Prospects by leading Player …
Microfiber leather is a cross-industry product, its development of technology and application related to textiles, plastics, chemicals and other field. The main raw materials of microfiber leather are polyurethane pulp, low density polyethylene, nylon chips, etc.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/global-microfiber-leather-market-2/47195/#requestforsample
Scope of the Report:
Microfiber Leather production are mainly concentrated in China and Japan at present, the output of this two regions occupy global production more than 80%. Microfiber leather production…
Global Data Monetization Market 2018-2025 Growth Analysis by Key Players, Accent …
Data monetization, a form of monetization, is the act of generating measurable economic benefits from available data sources. Typically these benefits accrue as revenue or expense savings, but may also include market share or corporate market value gains. Data monetization leverages data generated through business operations, available exogenous data or content, as well as data associated with individual actors such as that collected via electronic devices and sensors participating in…
Global Wireline Services Market Emerging Trends and Prospects by leading Players …
Wireline Service is the routine maintenance of a wellbore with wireline tools or any other devices so that well completion operations can be further worked upon. The service uses a cabling technology that a wireline service provider in oil and gas exploration and production business provides. This cabling technology together with the tools perform functions like intervening, pipe recovery and reservoir evaluation, etc.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/global-wireline-services-market/47193/#requestforsample
Scope of the…
More Releases for USD
$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com.
There is a $3,000,000…
Primary Alkaline Batteries Market Worth USD 14.58 Billion USD by 2026
The Global Primary Alkaline Batteries market size was valued at 10.31 Billion USD in 2019 and is projected to reach 14.58 Billion USD by 2026, at a CAGR of 5% during the forecast period.
An Primary Alkaline Batteries is a type of primary battery, which derives its energy from the reaction between zinc metal and manganese dioxide.
Get Detailed Analysis of COVID-19 Impact on Primary Alkaline Batteries Market @ https://reports.valuates.com/request/sample/QYRE-Othe-0I169/Global_Primary_Alkaline_Battery_Market
This report presents…
IOT Solutions Market worth USD 553.9 million USD by 2026
"The global IoT solutions market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cybersecurity as a service market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa."
These days many businesses are adopting a market research report…
Eubiotics Market Set to Exceed USD USD 8.60 Billion by 2026
According to a new study published by Polaris Market Research the global eubiotics market is anticipated to reach USD 8.60 billion by 2026. The tightening and stringent restrictions on the use of antibiotic growth promoters along with the surging consumer pressure on food safety and consumer preferences are expected to be the major factors driving demand for these products that work as substitutes to in-feed eubiotics.
Eubiotics or specific organic…
Polyurethane Dispersions Market worth USD 2.04 Billion USD by 2020
The report " Polyurethane Dispersions Market by Type (Water-Based Polyurethane Dispersions and Solvent-Based Polyurethane Dispersions), by Application (Coatings, Adhesives & Sealants, Synthetic Leather Production, Fiber Glass Sizing, and Others) - Trends & Forecasts to 2020", The global polyurethane dispersions market is projected to reach USD 2.04 Billion by 2020 at a CAGR of 6.8% between 2015 and 2020. This growth is fueled by the high potential from the textile and…
Retail Analytics Market worth USD 5.1 Billion USD by 2020
According to a new market research report "Retail Analytics Market by Business Function (Marketing and Customer Analytics, Merchandizing and In-Store Analytics, Supply Chain Analytics, Strategy and Planning), by Type, by Solutions and by Services - Global Forecast and Analysis to 2020", defines and segments the global retail analytics market on the basis of business function, solutions, services, deployment types, and regions along with providing an in-depth analysis and market size…
